AMR Centre candidate targets superbugs with problem metallo-β-lactamase enzymes
The AMR Centre has nominated a preclinical candidate in its program that tackles drug resistance conferred by NDM-1 and other metallo-β-lactamases (MBL).
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
